MarketCapTrends
STOK

Stoke Therapeutics Inc. (STOK)

NASDAQ · Healthcare

Stoke Therapeutics Inc. annual/quarterly total liabilities history from 2022 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Stoke Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 66.0M, a 55.12% increase year-over-year.
  • Stoke Therapeutics Inc. total liabilities for 2025 were 66.0M, a 55.12% increase from 2024.
  • Stoke Therapeutics Inc. total liabilities for 2024 were 42.5M, a 38.16% decrease from 2023.
  • Stoke Therapeutics Inc. total liabilities for 2023 were 68.8M, a 3.43% decrease from 2022.
  • Stoke Therapeutics Inc. total liabilities for 2022 were 71.2M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Stoke Therapeutics Inc. Annual Total Liabilities (Millions of US $)
2025$66
2024$43
2023$69
2022$71
Stoke Therapeutics Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$66
2024-12-31$43
2023-12-31$69
2022-12-31$71

Stoke Therapeutics Inc. Total Liabilities — FAQ

Stoke Therapeutics Inc. (STOK) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see STOK's total liabilities history?

The chart and table above show Stoke Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.